Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Department of Anesthesiology, Critical Care Medicine and Emergency, SS. Annunziata Hospital, Chieti, Italy.
Pierluigi Di Giannatale studies how to optimize breathing support for patients suffering from severe lung problems, particularly those who have also sustained brain injuries. One of his key research areas involves comparing different devices used in ventilation, specifically how a heated humidifier can be more beneficial than traditional breathing devices. By managing the amount of air breathed in, he aims to improve both the respiratory mechanics and the flow of blood to the brain without causing additional harm, which is crucial for recovery in these vulnerable patients.
Key findings
Lowering the tidal volume by 120 ml resulted in improved management of breathing pressure for brain-injured ARDS patients.
Switching from a heat and moisture exchanger to a heated humidifier did not compromise blood flow to the brain.
The new ventilation strategy may lead to better overall health outcomes for patients with both brain injuries and ARDS.
Frequently asked questions
Does Dr. Di Giannatale study brain injuries?
Yes, he specifically focuses on brain injuries and how they affect breathing management in patients with ARDS.
What treatments has Dr. Di Giannatale researched?
He has researched ventilation strategies, comparing the effectiveness of heated humidifiers to traditional devices in improving breathing for patients.
Is Dr. Di Giannatale's work relevant to patients with ARDS?
Absolutely, his work directly addresses ways to enhance respiratory management for patients suffering from ARDS.
Publications in plain English
Corticosteroid and antimicrobial therapy in macrolide-resistant pneumococcal pneumonia porcine model.
2025
Intensive care medicine experimental
Motos A, Yang M, Battaglini D, Yang H, Meli A +18 more
Plain English This study looked at how different antibiotic combinations and corticosteroids affect pneumonia caused by a drug-resistant bacteria in pigs. They found that a combination of ceftriaxone, azithromycin, and methylprednisolone not only killed the bacteria effectively but also reduced inflammation better than other combinations. This is important because it shows a potential treatment option for pneumonia that doesn't respond to standard antibiotics, specifically for severe cases.
Who this helps: This helps patients with severe pneumonia caused by macrolide-resistant bacteria.
Prediction of ventilator-associated pneumonia outcomes according to the early microbiological response: a retrospective observational study.
2022
The European respiratory journal
Ceccato A, Dominedò C, Ferrer M, Martin-Loeches I, Barbeta E +8 more
Plain English This study looked at patients who developed ventilator-associated pneumonia (VAP) to see how the early results of follow-up tests could predict their recovery outcomes. Out of 157 patients, researchers found that 48% had persistent infections, 16% had superinfections, and 41% had eradication of the pathogens three days after their initial diagnosis. Those with superinfections had the highest mortality rates and fewer days free from the ventilator, highlighting the importance of monitoring infections closely to improve treatment strategies.
Who this helps: This research helps patients in intensive care and the doctors treating them by guiding better management of VAP.
A rare case of a patient with cystinosis and COVID-19 pneumonia with difficult weaning from mechanical ventilation: the "pocus force".
2022
Journal of anesthesia, analgesia and critical care
Vetrugno L, Angelini V, Smiraglia SA, Saraceni E, Di Giannatale P +1 more
Plain English This study looked at a 39-year-old woman with cystinosis who also developed severe COVID-19 pneumonia and had trouble being taken off mechanical ventilation. The researchers found that she had a weak diaphragm, which made it hard for her to breathe on her own. They believe using ultrasound to check diaphragm strength can help doctors understand and manage similar cases better.
Who this helps: This helps doctors treating patients with cystinosis and respiratory failure.
Safety considerations of current drug treatment strategies for nosocomial pneumonia.
2021
Expert opinion on drug safety
Ceccato A, Di Giannatale P, Nogas S, Torres A
Plain English This study looked at the safety of different antibiotics used to treat pneumonia that patients get while in the hospital (known as nosocomial pneumonia). It found that while beta-lactam antibiotics are frequently used, 6% to 25% of patients can have allergic reactions, but most of these reactions can be resolved with proper evaluation. Using the right combination of antibiotics based on individual patient needs can improve treatment outcomes and reduce unnecessary use of broad-spectrum antibiotics.
Who this helps: This benefits patients with nosocomial pneumonia and the doctors treating them.
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study.
2021
Critical care (London, England)
Ceccato A, Russo A, Barbeta E, Oscanoa P, Tiseo G +9 more
Plain English This study looked at whether corticosteroids can help patients with severe community-acquired pneumonia (CAP) who are experiencing high levels of inflammation. Out of 610 patients analyzed, those who received corticosteroids had a lower death rate after 28 days—18% compared to 31% for those who didn't receive them. This is important because it suggests that corticosteroids could improve survival for critically ill pneumonia patients facing severe complications like septic shock.
Who this helps: This helps patients with severe pneumonia, especially those requiring intensive care and experiencing septic shock.
Tidal Volume Lowering by Instrumental Dead Space Reduction in Brain-Injured ARDS Patients: Effects on Respiratory Mechanics, Gas Exchange, and Cerebral Hemodynamics.
Plain English This study looked at how switching from a heat and moisture exchanger (HME) to a heated humidifier (HH) could help lower the amount of air (tidal volume) given to brain-injured patients with acute respiratory distress syndrome (ARDS). Researchers found that using the HH allowed a reduction in tidal volume by 120 ml and helped improve the management of breathing pressure without harming blood flow to the brain. This matters because it shows a safer way to ventilate patients with both brain injuries and ARDS, potentially leading to better outcomes.
Who this helps: This helps brain-injured patients suffering from ARDS and their doctors.
Physiological effects of high-flow oxygen in tracheostomized patients.
2019
Annals of intensive care
Natalini D, Grieco DL, Santantonio MT, Mincione L, Toni F +5 more
Plain English This study looked at how high-flow oxygen therapy affects patients who have a tracheostomy (a tube in their throat to help with breathing). Researchers tested three different flow rates (10, 30, and 50 liters per minute) and found that using 50 liters per minute improved oxygen levels by 40 mmHg, lowered the breathing rate by nearly 2 breaths per minute, and increased airway pressure. These results are important because they show that higher flow rates can significantly enhance breathing for these patients.
Who this helps: This helps patients with tracheostomies and their healthcare providers.